Puration Inc. (OTC: PURA) Breaking News -
October 10, 2018
Puration, Inc. Announces New Goldman Small Cap
Research Report With Speculative-Buy Rating and Target $0.25 PPS
DALLAS, Oct. 10, 2018- Puration, Inc. (USOTC:
PURA) (“PURA”) today
announced that Goldman Small Cap Research issued an updated research report on
the Company. The report includes a 'speculative-buy' rating with a target
price-per-share of $0.25. The report provides an in-depth overview and analysis
of Puration's successes, approach, new initiatives, and upcoming milestones. To
view the report, along with disclosures and disclaimers, visit
http://www.GoldmanResearch.com or
https://www.purationinc.com/goldman-research/.
Puration Goldman Small Cap Research Report Highlights
Puration, Inc. is a leading Texas-based, CBD-infused beverage provider. The
Company’s flagship product, EVERx, which was introduced in 2017, targets the
sports nutrition market. Puration plans to introduce new beverages as well as
grow its product portfolio organically as well as through targeted acquisitions.
As of October 2018, the Company was set to spin off its cannabis cultivation
segment to focus its efforts exclusively on its high-growth core CBD-infused
beverage business.
According to Hemp Business Journal, the overall hemp-based CBD market is
forecast to grow from $820 million in 2017 to $1.9 billion in 2022 and given
that the market remains fragmented, fast-growing PURA is well positioned to
capture market share very quickly.
In the Opportunity Research update, analyst Rob Goldman discusses the Company’s
compelling positioning, exciting opportunities, and innovative subsidiary
spin-off plans.
Goldman noted, “PURA is one of the leading players in the fast-growing CBD-infused
beverage arena. In fact, Puration’s flagship product has enjoyed 600% sales
growth since its introduction in
2017. Leveraging this growth, Puration plans to execute M&A and introduce new
beverage products. With double the number of CBDs found in most beverages,
PURA’s EVERx CBD Infused Sports Waters reduce pain and muscle soreness.”
“Major beverage companies such as Constellation Brands, Coca-Cola have already
begun joint venture with companies in the cannabis space or are devising their
strategies. These recent events bode well for companies like Puration which has
demonstrated sales and a strong customer base sports nutrition and fitness. To
focus on its core, high-growth beverage business, PURA announced a spin-off of
its cannabis cultivation segment, effective 10/11/18. This event could turn into
a future bonus for shareholders.”
“In our view, these shares are trading at very low levels and offer substantial
upside. A snapshot of the current valuations of 2 publicly traded cannabis
beverage peers illustrates that PURA trades at a lower market cap, despite much
higher sales. Thus, we believe the stock could reach higher levels as PURA
executes its sales and M&A strategy.”
About Goldman Small Cap Research: Founded in 2009 by former Piper Jaffray
analyst and mutual fund manager Rob Goldman, Goldman Small Cap Research produces
sponsored and non-sponsored small cap and microcap stock research reports,
articles, stock market blogs, and popular investment newsletters.
Goldman Small Cap Research is not in any way affiliated with Goldman Sachs & Co.
This press release contains excerpts of our most recently published sponsored
company research report on Puration, Inc. which carries a rating and a price
target. The information used and statements of fact made have been obtained from
sources considered reliable but we neither guarantee nor represent the
completeness or accuracy. Goldman Small Cap Research relied solely upon
information derived from Puration, Inc. (“the Company”) authorized press
releases or legal disclosures made in its filings with the U.S. Securities and
Exchange Commission http://www.sec.gov.
Separate from the factual content of our report about the Company, we may from
time to time include our own opinions about the Company, its business, markets
and opportunities. Any opinions we may offer about the Company are solely our
own, and are made in reliance upon our rights under the First Amendment to the
U.S. Constitution, and are provided solely for the general opinionated
discussion of our readers. Our opinions should not be considered to be complete,
precise, accurate, or current investment advice. Statements herein may contain
forward-looking statements and are subject to significant risks and
uncertainties affecting results.
A Goldman Small Cap Research report, update, newsletter, article, trading alert,
corporate profile, or press release is not intended as an offering,
recommendation, or a solicitation of an offer to buy or sell the securities
mentioned or discussed is to be used for informational purposes only. Please
read all associated full disclosures, disclaimers, and analyst background on our
website before investing. Neither Goldman Small Cap Research nor its parent is a
registered investment adviser or broker-dealer with FINRA or any other
regulatory agency. To download this research report or any of our research, view
our disclosures and disclaimers, or for more information, visit
www.goldmanresearch.com. Goldman Small Cap Research was compensated $3500 by the
Company for research and distribution services, including the production of this
press release.
About Puration, Inc. (OTC - PURA) Puration, Inc. is a leading Texas-based, CBD-infused
beverage provider. The Company’s flagship product, EVERx, which was introduced
in 2017, targets the sports nutrition market. Puration plans to introduce new
beverages as well as grow it product portfolio organically as well as through
targeted acquisitions. As of October 2018, the Company was set to spin off its
cannabis cultivation segment to focus its efforts exclusively on its high-growth
core CBD-infused beverage business.
For more information, please visit:
www.PurationInc.com
Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the meaning of the
Securities Litigation Reform Act. The statements reflect the Company's current
views with respect to future events that involve risks and uncertainties. Among
others, these risks include the expectation that any of the companies mentioned
herein will achieve significant sales, the failure to meet schedule or
performance requirements of the companies' contracts, the companies' liquidity
position, the companies' ability to obtain new contracts, the emergence of
competitors with greater financial resources and the impact of competitive
pricing. In the light of these uncertainties, the forward-looking events
referred to in this release might not occur. These statements have not been
evaluated by the Food and Drug Administration. These products are not intended
to diagnose, treat, cure, or prevent any disease.
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800) 861-1350
Goldman Small Cap Research
Rob Goldman, Analyst
410-609-7100
rob@goldmanresearch.com
Puration Inc Sets Sights On 2018 Revenue Benchmark
To Carve Out Leadership Stake In $1 Billion Cannabis Beverage Market Segment
DALLAS, Oct. 09, 2018 (- Puration, Inc. (USOTC:
PURA) (“PURA”) today announced
setting its sights on breaking through the $1 million revenue benchmark in
2018. PURA is a rapidly growing cannabis beverage producer and management
believes sales could exceed $1 million this year, 2018. The company introduced
EVERx CBD Sports Water last year, and it has become the leading cannabis
beverage brand name in the sports nutrition marketplace. Distribution is
growing rapidly. The company has just launched its first production run with
its new labels to fill outstanding
orders within new regions in the United States (and internationally). The company’s
first THC infused beverage, THCSavor, is in the works and is expected to launch
soon. The company also recently
announced a pending acquisition to add yet a third cannabis beverage. According
to a report by Brightfield Group, the hemp and CBD category alone is expected to
be a $1 billion market by 2020 in the U.S.
EVERx CBD Sports Water has become the
leading cannabis beverage brand name in the sports nutrition marketplace.
PURA announced
last week the spinoff of its cannabis cultivation business. The spinoff is part
of the overall strategy for Puration to concentrate ongoing business development
efforts on the company’s flourishing cannabis infused beverage business. The
spinoff announced last week has been effected through the execution of a
securities exchange agreement with Nouveau Life
Pharmaceuticals, Inc., (USOTC:
NOUV) (“NOUV”). PURA has sold
its cannabis cultivation business irn exchange for a convertible purchase note
issued by NOUV. All of the NOUV common shares
issued in conversion of the purchase note are slated for distribution to PURA
shareholders in a dividend distribution following a recapitalization of NOUV.
More details on the company’s rapidly
expanding cannabis beverage business to include further details on the spinoff
transaction will be included in an online presentation this Thursday, October
11th, 2018.
Learn more about Puration at www.purationinc.com
Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the meaning of the
Securities Litigation Reform Act. The statements reflect the Company's current
views with respect to future events that involve risks and uncertainties. Among
others, these risks include the expectation that any of the companies mentioned
herein will achieve significant sales, the failure to meet schedule or
performance requirements of the companies' contracts, the companies' liquidity
position, the companies' ability to obtain new contracts, the emergence of
competitors with greater financial resources and the impact of competitive
pricing. In the light of these uncertainties, the forward-looking events
referred to in this release might not occur. These statements have not been
evaluated by the Food and Drug Administration. These products are not intended
to diagnose, treat, cure, or prevent any disease.
Puration, Inc.
Brian Shibley,
info@aciconglomerated.com
(800) 861-1350
A photo accompanying this announcement is
available at http://www.globenewswire.com/NewsRoom/AttachmentNg/8f1ebf50-0016-4374-ae54-22781fff71e7
Source: Puration Inc.
---------------------------------------
About PURA:
Puration is engaged in the development of standardized and repeatable cannabis
extraction processes that can deliver a consistent and high-quality concentrate
for infusion into consumer food and beverage products that appeal to the
recreational and wellness market segments.
The Company recently released details regarding the upcoming launch of an
extraction facility in the State of Colorado where the extraction process can be
utilized for both the ongoing development of cannabis treatments at the same
time benefiting from the extraction and selling oil from marijuana into the
legal recreational market in Colorado.
Puration, Inc. (PURA) entered the emerging cannabis sector last July when it
executed an agreement to acquire select operating assets from North American
Cannabis Holdings, Inc. (USMJ). Since that time, Puration has focused on
developing from the acquired operating assets a standardized and repeatable
extraction process to produce a variety of high-quality and consistent cannabis
extracts. Previously, Puration had been developing and marketing water
purification technology. In fact, Puration’s portable personal water filtered
bottles remain currently available on select retails shelves.
Today, the water purification business at Puration is secondary and the
development of a leading cannabinoid extraction capacity is the Company’s
primary focus. The purpose of developing a leading cannabinoid extraction
capacity is to provide the Company with the best available source of extracts
for infusion into health and wellness consumer products. While the ‘Puration’
name was originally coined to represent the Company’s water purification
business, the name still seems to be a good fit with the current cannabinoid
extraction focus. Accordingly, no corporate name change is planned.
Puration extracts have been infused into a sports and fitness nutritional
supplement line under the brand Name EVERx available now on a limited test
market basis.
Puration’s progress since its July entry into the cannabis sector has to date
not been widely publicized. Work last year quietly focused on developing
extraction processes and on opening an extraction lab and infusion facility in
Colorado as well as securing a large scale, commercial hemp farming operation in
China. Management is just now beginning to make the Company’s past and coming
progress more public.
$3 Million Cannabis Extraction 1st Year Revenue Plan
Executive Summary
Puration, Inc. has been working independently and with various partners to
develop standardized and repeatable cannabis extraction processes to deliver
consistent, high-quality concentrates for infusion into food and beverage
consumer products for the recreational and wellness market segments.
While Puration anticipates marijuana legalization to progress, management
anticipates ‘smoking’ limitations and restrictions to endure in light of the
known health risks associated with smoking tobacco.
Cannabis
infused food and beverage products exist in the market today, but the quality
and intensity of infused concentrates can be unpredictable.
The packaging and marketing of ‘edibles’ is largely undeveloped market wide with
many products packaged into plain envelopes, paper sacks and cardboard mailing
tubes with low graphic quality sticker labels. Basic retail merchandizing
practices are virtually non-existent. Advertising is limited primarily to
homegrown social media campaigns.
Puration intends to build collaboration agreements to infuse Puration branded,
high quality, consistent concentrates into select food and beverage consumer
products.
Strategic Overview
Puration’s success begins with a clear operational focus and equally clear sales
and marketing focus.
Extraction Operation
Through research and industry experience, various cannabis extracts have
demonstrated a variety of effective pharmaceutical, wellness and recreational
applications. Puration has identified specific extracts applicable to targeted
wellness and recreational applications and initiated development and production.
Puration will continue to bolster its capacity for delivering consistent high
quality extracts by:
1. Building and operating and continuously expanding in-house extraction
facilities and
2. Continuously improving its extraction process through independent research
and experience, and through research and experience with select extraction
partners.
Sales & Marketing
Puration will build a brand for quality and consistency of its extracts by
1. Having a great product
2. Represented by a professionally developed recognizable image
3. Co-marketed with existing brand name food and beverage consumer products.
$3 Million Forecast
The Company has entered into negotiations with a number of food and beverage
consumer product companies regarding collaborations to infuse a co-branded
Puration extract. The target sales objective of each collaboration agreement is
$1 million dollars within the first year. Puration anticipates three
collaboration agreements to be finalized promptly. The Company has more than
three collaboration agreements currently under development. If Puration enters
into more than three collaboration agreements, management may refine its
preliminary revenue forecast upward..
SOURCE: http://www.purationinc.com/
Disclaimer
FN Media Group LLC (FNMG) owns and operates
FinancialNewsMedia.com (FNM)
which is a third party publisher that disseminates electronic information
through multiple online media channels. FNMG's intended purposes are to deliver
market updates and news alerts issued from private and publicly trading
companies as well as providing coverage and increased awareness for companies
that issue press to the public via online newswires. FNMG and its affiliated
companies are a news dissemination and financial marketing solutions provider
and are NOT a registered broker/dealer/analyst/adviser, holds no investment
licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's
market updates, news alerts and corporate profiles are NOT a solicitation or
recommendation to buy, sell or hold securities. The material in this release is
intended to be strictly informational and is NEVER to be construed or
interpreted as research material. All readers are strongly urged to perform
research and due diligence on their own and consult a licensed financial
professional before considering any level of investing in stocks. The companies
that are discussed in this release may or may not have approved the statements
made in this release. Information in this release is derived from a variety of
sources that may or may not include the referenced company's publicly
disseminated information. The accuracy or completeness of the information is not
warranted and is only as reliable as the sources from which it was obtained.
While this information is believed to be reliable, such reliability cannot be
guaranteed. FNMG disclaims any and all liability as to the completeness or
accuracy of the information contained and any omissions of material fact in this
release. This release may contain technical inaccuracies or typographical
errors. It is strongly recommended that any purchase or sale decision be
discussed with a financial adviser, or a broker-dealer, or a member of any
financial regulatory bodies. Investment in the securities of the companies
discussed in this release is highly speculative and carries a high degree of
risk. FNMG is not liable for any investment decisions by its readers or
subscribers. Investors are cautioned that they may lose all or a portion of
their investment when investing in stocks. This release is not without bias, and
is considered a conflict of interest if compensation has been received by FNMG
for its dissemination. To comply with Section 17(b) of the Securities Act of
1933, FNMG shall always disclose any compensation it has received, or expects to
receive in the future, for the dissemination of the information found herein on
behalf of one or more of the companies mentioned in this release. For current
services performed FNMG was compensated two thousand dollars for Puration Inc. news coverage by a non-affiliated third party.
FNMG HOLDS NO SHARES OF Puration Inc.
This release contains "forward-looking statements" within the meaning of Section
27A of the Securities Act of 1933, as amended, and Section 21E the Securities
Exchange Act of 1934, as amended and such forward-looking statements are made
pursuant to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. "Forward-looking statements" describe future expectations,
plans, results, or strategies and are generally preceded by words such as "may",
"future", "plan" or "planned", "will" or "should", "expected," "anticipates",
"draft", "eventually" or "projected". You are cautioned that such statements are
subject to a multitude of risks and uncertainties that could cause future
circumstances, events, or results to differ materially from those projected in
the forward-looking statements, including the risks that actual results may
differ materially from those projected in the forward-looking statements as a
result of various factors, and other risks identified in a company's annual
report on Form 10-K or 10-KSB and other filings made by such company with the
Securities and Exchange Commission. You should consider these factors in
evaluating the forward-looking statements included herein, and not place undue
reliance on such statements. The forward-looking statements in this release are
made as of the date hereof and FNMG undertakes no obligation to update such
statements.
|